Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Timing of birth and risk of multiple sclerosis: population based study.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Sex hormones and multiple sclerosis: another informative failure.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
A monoclonal natural human IgM protects axons in the absence of remyelination.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Autoimmune sleep disorders.
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids.
CHMP issues positive opinion for TECFIDERA™ (dimethyl fumarate) as a first-line treatment for multiple sclerosis in the European Union
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.

Pages